Home > Press Releases > Lizza Named to the NJBIZ 2021 Law Power 50 List

Lizza Named to the NJBIZ 2021 Law Power 50 List

Published: 07/28/2021
Services: Intellectual Property Litigation

Saul Ewing Arnstein & Lehr LLP is proud to announce that Charles M. Lizza, Vice Chair of the Firm’s Litigation Department and Chair of its Life Sciences & IP Litigation Practice, was named to the NJBIZ 2021 Law Power 50 list. This is the third year in a row that Mr. Lizza has been included on this list of the state's top lawyers. Professionals are selected for the list based on their legal acumen and the results they have achieved in the state. 

Mr. Lizza currently serves as lead New Jersey litigation counsel in more than 40 patent cases for approximately two dozen major pharmaceutical companies. Examples of his work include representation of Helsinn Healthcare S.A. in two major trial victories against Teva and Dr. Reddy’s involving the Aloxi brand drug product (market value of judgments $3.2 billion) and representing Celgene Corp. in defending its Revlimid drug, a treatment for multiple myeloma and blood disorders, which produces annual sales of about $6 billion. Mr. Lizza's profile notes "…it’s no secret that the pharmaceutical industry plays a pivotal role in the New Jersey economy. And Lizza helps these drugmakers protect some of their most valuable assets: intellectual property.”